As it is known to be amplified and/or mutated in up to 40% of malignant glioma, EGFR associated with glioma in the Chinese population in some study, was one of the key oncogene subjected to targeted therapy for glioma in China [20–21]. Here, EGFR is linked to central nervous system cancer.